Association between apolipoprotein E ε4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia

Archives of Neurology

Volumn 55, Issue 8, 1998, Pages 1065-1069

  Jonker, Cees ^a,b   Schmand, Ben ^a,b   Lindeboom, Jaap ^a   Havekes, Louis M ^c   Launer, Lenore J ^d,e  

^a SLOTERVAART HOSPITAL   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c TNO   (Netherlands)

^d NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^e ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4;

AGED; ALLELE; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; FEMALE; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; NEUROPSYCHOLOGICAL TEST; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

AGED; AGED, 80 AND OVER; ALLELES; APOLIPOPROTEINS E; COGNITION; DEMENTIA; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; NEUROPSYCHOLOGICAL TESTS; PHENOTYPE; RESIDENCE CHARACTERISTICS; SEVERITY OF ILLNESS INDEX;

EID: 0031847803     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.55.8.1065     Document Type: Article

References (36)

1. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc Natl Acad Sci U S A. 1993;90:1977-1981.
2. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele ∈4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 1993;43:1467-1472.
3. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993;261:921-923.
4. Feskens EJM, Havekes LM, Kalmijn S, Launer LJ, Kromhout D. Apolipoprotein E ∈4 allele and cognitive decline in elderly men. BMJ. 1994;309:1202-1206.
5. Henderson AS, Easteal S, Jorm AF, et al. Apolipoprotein E allele ∈4, dementia, and cognitive decline in a population sample. Lancet. 1995;346:1387-1390.
6. Hyman BT, Gomez-Isla T, Briggs M, et al. Apolipoprotein E and cognitive change in an elderly population. Ann Neurol. 1996;40:55-66.
7. Petersen RC, Smith GE, Ivnik RJ, et al. Apolipoprotein status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA. 1995;273:1274-1278.
8. Tierney MC, Szalai JP, Snow WG, et al. Prediction of probable Alzheimer's disease in memory-impaired patients: a prospective longitudinal study. Neurology. 1996;46:661-665.
9. Tierney MC, Szalai JP, Snow WG, et al. A prospective study of the clinical utility of ApoE genotype in the prediction of outcome in patients with memory impairment. Neurology. 1996;46:149-154.
10. Dal Forno G, Rasmusson X, Brandt J, et al. Apolipoprotein E genotype and rate of decline in probable Alzheimer's disease. Arch Neurol. 1996;53:345-350.
11. Sarochan M, Förstl H, Sattel H, Zerfass R, Czech C, Beyreuther K. Apolipoprotein E genotype does not promote the clinical progression of manifest Alzheimer's disease [letter]. Dementia. 1996;7:120.
12. Norrman J, Brookes AJ, Yates C, St Clair D. Apolipoprotein E genotype and its effect on duration and severity of early and late onset Alzheimer's disease. Br J Psychiatry. 1995;176:533-536.
13. Corder EH, Saunders AM, Strittmatter WJ, et al. Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease. Neurology. 1995;45:1323-1328.
14. Growdon JH, Locascio JJ, Corkin S, Gomez-Isla T, Hyman BT. Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease. Neurology. 1996;47:444-448.
15. Kurz A, Egensperger R, Haupt M, et al. Apolipoprotein E ∈4 allele, cognitive decline, and deterioration of everyday performance in Alzheimer's disease. Neurology. 1996;47:440-443.
16. Asada T, Kariya T, Yamagata Z, Kinoshita T, Asaka A. Apolipoprotein E ∈4 allele and cognitive decline in patients with Alzheimer's disease. Neurology. 1996;47:603.
17. Bondi MW, Salmon DP, Monsch AU, et al. Episodic memory changes are associated with the ApoE-∈4 allele in nondemented older adults. Neurology. 1995; 45:2203-2206.
18. Hooijer C, Dinkgreve M, Jonker C, Lindeboom J. Short screening tests for dementia in the elderly population, I: a comparison between AMTS, MMSE, MSQ and SPMSQ. Int J Geriatr Psychiatry. 1992;7:559-571.
19. Launer LJ, Dinkgreve MAHM, Jonker C, Hooijer C, Lindeboom L. Are age and education independent correlates of the Mini-Mental State Exam performance of community-dwelling elderly? J Gerontol B Psychol Sci Soc Sci. 1993;48:P271-P277.
20. Folstein MF, Folstein S, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
21. Roth M, Huppert FA, Tym E, Mountjoy CQ. CAMDEX: The Cambridge Examination for Mental Disorders of the Elderly. NewYork, NY: Cambridge University Press; 1988.
22. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition. Washington, DC: American Psychiatric Association; 1987.
23. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan DL. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944.
24. Berg L. Clinical Dementia Rating (CDR). Psychopharmacol Bull. 1988;24:637-639.
25. Havekes L, De Knijff P, Beiseigel U, et al. A rapid micromethod for apolipoprotein E phenotyping directly in serum. J Lipid Res. 1987;28:445-446.
26. SAS Institute. SAS/STAT Software: Changes and Enhancements Through Release 6.11. Cary, NC: SAS Institute Inc; 1996:531-656.
27. Evans DE, Beckett LA, Field TS, et al. Apolipoprotein E ∈4 and incidence of Alzheimer disease in a community population of older persons. JAMA. 1997;277:822-824.
28. Roses AD. Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease. Ann Neurol. 1995;38:6-14.
29. Seshadri S, Drachman DA, Lippa CF. Apolipoprotein E ∈4 allele and the lifetime risk of Alzheimer's disease. Arch Neurol. 1995;52:1074-1079.
30. Roses AD, Strittmatter WJ, Pericak-Vance MA, et al. Clinical application of apolipoprotein E genotyping to Alzheimer's disease. Lancet. 1994;343:1564-1565.
31. Ma J, Yee A, Brewer HB, Potter H. Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. Nature. 1994;372:92-94.
32. Strittmatter WJ, Weisgraber KH, Goedert M, et al. Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Exp Neurol. 1994;125:163-171.
33. Ohm TG, Kirca M, Bohl J, et al. Apolipoprotein E polymorphism influences not only senile plaque load but also Alzheimer-type neurofibrillary tangle formation. Neuroscience. 1995;66:583-587.
34. Roses AD. Apolipoprotein E alleles as risk factors in Alzheimer disease. Annu Rev Med. 1996;47:387-400.
35. Plassman BL, Breitner JCS. Apolipoprotein E and cognitive decline in Alzheimer's disease. Neurology. 1996;47:317-320.
36. Bird TD. Apolipoprotein E genotyping in the diagnosis of Alzheimer's disease: a cautionary view. Ann Neurol. 1995;38:2-4.